Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

robin_washington

Gilead’s CFO and Executive Vice President to depart in 2020

May 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma

Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, …
Appointment

Will mobile phones save the NHS?

May 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, feature, mhealth, mobile health, pharma

The NHS is sick. According to politicians and NHS chiefs, the cure involves a strong dose of mHealth. Louis Goss …
Feature
shutterstock_159488225

Astellas and Cytokinetics’ reldesemtiv falls short at Phase 2 in ALS

May 7, 2019 Manufacturing and Production, Sales and Marketing Astellas, als, amyotrophic lateral sclerosis, cytokinetics, pharma

Cytokinetics has announced at the American Academy of Neurology (AAN) that its fast skeletal muscle troponin activator (FSTA) reldesemtiv fell …
News

Lundbeck acquire Abide Therapeutics in deal worth $400 million

May 7, 2019 Manufacturing and Production, Sales and Marketing Abide Therapeutics, Lundbeck, endocannabinoid system, neuropathic pain, tourette's

Danish firm Lundbeck has agreed to acquire San Diego-based biotech Abide Therapeutics as part of a deal worth $400 million. …
News
gwpharma

GW Pharma’s Epidiolex scores in rare childhood onset epilepsy Phase 3 trial

May 7, 2019 Manufacturing and Production, Sales and Marketing CBD, Epidiolex, GW Pharma, cannabidiol, cannabis, epilepsy, tsc

GW Pharma’s Epidiolex has shown positive Phase 3 trial results for the fifth time in a row, after meeting primary …
News

FDA approves first two drugs for transthyretin amyloid cardiomyopathy

May 7, 2019 Manufacturing and Production, Sales and Marketing FDA, Pfizer, US, Vyndamax, Vyndaqel, pharma

The FDA has approved its first two therapies for the treatment of cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM), …
News
450px-official_portrait_of_matt_hancock_crop_2

Health Secretary Matt Hancock says he will not rule out ‘compulsory vaccination’

May 7, 2019 Manufacturing and Production, Sales and Marketing Matt Hancock, infectious diseases, pharma, public health, vaccines

Health Secretary Matt Hancock has said he would not rule out ‘compulsory vaccination,’ as he argued that those spreading anti-vaccine …
News
haseeb-ahmad-abpi-vice-president-4

ABPI names Novartis’ Haseeb Ahmad as new President

May 3, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Novartis, appointment, pharma

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 3, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Gilead, autism, dementia, opioids, pharma

This week was marked by the failure of two Phase 3 trials after both Eli Lilly and Gilead suffered from …
News

Sanofi’s Dengvaxia becomes first FDA-approved dengue vaccine, but with caveats…

May 2, 2019 Sales and Marketing FDA, Sanofi, dengue, dengvaxia, pharma

Sanofi has announced that the FDA has granted authorisation to its tetravalent vaccine Dengvaxia for prevention of dengue disease originating …
News
dw-anzcxqaqavhl

FDA refuses to review Nabriva’s injectable antibiotic for urinary tract infections

May 1, 2019 Research and Development, Sales and Marketing Contepo, Nabriva, pharma, urinary tract infections

Biopharma firm Nabriva Therapeutics has revealed that its antibiotic Contepo (fosfomycin) has been rejected for review by the FDA as …
News
robin_washington

Gilead’s CFO and Executive Vice President to depart in 2020

May 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma

Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, …
News
gsk_boronia_australia

GSK’s Benlysta becomes first FDA-approved IV therapy for paediatric lupus

April 30, 2019 Manufacturing and Production, Sales and Marketing Benlysta, FDA, GSK, Lupus, US, pharma

GSK has scored approval in the US with Benlysta (belimumab) for the treatment of systemic lupus erythematosus (SLE) in paediatric …
News

The price of access: Can the NHS afford Orkambi?

April 29, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, NHS, NICE, Orkambi, UK, Vertex, access, cystic fibrosis, feature, pharma, pricing

The impasse over access to Vertex’s Orkambi for cystic fibrosis patients in England and Wales has revealed the cracks in …
Feature
shutterstock_243110086

Sanofi and Lexicon’s Zynquista scores EU approval for type 1 diabetes patients

April 29, 2019 Sales and Marketing Lexicon, Sanofi, Type 1 diabetes, Zynquista, diabetes, pharma

The European Commission has authorised the use of Sanofi and Lexicon’s Zynquista (sotagliflozin) in Europe in the treatment of specific …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026